EAPP modulates the activity of p21 and Chk2

Cell Cycle

Volumn 10, Issue 13, 2011, Pages 2077-2082

  Andorfer, Peter ^a   Schwarzmayr, Ludwig ^a   Rotheneder, Hans ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Checkpoint; Chk2; DNA damage; EAPP; p21; Phosphorylation

Indexed keywords

CHECKPOINT KINASE 2; CYCLIN B1; ETOPOSIDE; KRUPPEL LIKE FACTOR 4; NOTCH RECEPTOR; PHOSPHOPROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN EAPP; PROTEIN P21; PROTEIN P53; RAS PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR RUNX; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANEUPLOIDY; BINDING SITE; BREAST CANCER; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; DEPHOSPHORYLATION; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INACTIVATION; GENOMIC INSTABILITY; IMMUNOPRECIPITATION; MITOSIS; PROGNOSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TUMOR CELL;

EID: 79960027085     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.13.16247     Document Type: Review

References (36)

1. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461:1071-8.
2. Lavin MF, Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007; 6:931-42. (Pubitemid 46658748)
3. Stracker TH, Petrini JH. The MRE11 complex: Starting from the ends. Nat Rev Mol Cell Biol 12:90-103.
4. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281:1674-7.
5. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281:1677-9. (Pubitemid 28435584)
6. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287:1824-7.
7. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 2000; 14:289-300. (Pubitemid 30106484)
8. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 1998; 20:398-400. (Pubitemid 28541643)
9. Rozan LM, El-Deiry WS. p53 downstream target genes and tumor suppression: A classical view in evolution. Cell Death Differ 2007; 14:3-9. (Pubitemid 44911889)
10. Das S, Boswell SA, Aaronson SA, Lee SW. p53 promoter selection: Choosing between life and death. Cell Cycle 2008; 7:154-7. (Pubitemid 351366513)
11. Efeyan A, Serrano M. p53: Guardian of the genome and policeman of the oncogenes. Cell Cycle 2007; 6:1006-10. (Pubitemid 46708570)
12. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25.
13. Gu Y, Turck CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory sub-unit. Nature 1993; 366:707-10. (Pubitemid 24036022)
14. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 22:1003-12.
15. Abbas T, Dutta A. p21 in cancer: Intricate networks and multiple activities. Nat Rev Cancer 2009; 9:400-14.
16. Broude EV, Demidenko ZN, Vivo C, Swift ME, Davis BM, Blagosklonny MV, et al. p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle 2007; 6:1468-71.
17. Blagosklonny MV. Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 2002; 1:391-3.
18. WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res 2003; 5:242-9.
19. Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage. Cell Cycle 2009; 8:253-6.
20. Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006; 6:11-23. (Pubitemid 43053649)
21. Novy M, Pohn R, Andorfer P, Novy-Weiland T, Galos B, Schwarzmayr L, et al. EAPP, a Novel E2F binding protein that modulates E2F-dependent transcription. Mol Biol Cell 2005; 16:2181-90. (Pubitemid 40632204)
22. Schwarzmayr L, Andorfer P, Novy M, Rotheneder H. Regulation of the E2F-associated phosphoprotein promoter by GC-box binding proteins. Int J Biochem Cell Biol 2008; 40:2845-53.
23. Andorfer P, Rotheneder H. EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell cycle arrest. Oncogene; 2011:In press.
24. Chen K, Ou XM, Wu JB, Shih JC. Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/ CDCA7L/JPO2 (R1) and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B. Molecular pharmacology 79:308-17.
25. van Vugt MA, Gardino AK, Linding R, Ostheimer GJ, Reinhardt HC, Ong SE, et al. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1 and Chk2 to inactivate the G(2)/M DNA damage checkpoint. PLoS Biol 8:1000287.
26. Lindqvist A, de Bruijn M, Macurek L, Bras A, Mensinga A, Bruinsma W, et al. Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J 2009; 28:3196-206.
27. Macurek L, Lindqvist A, Voets O, Kool J, Vos HR, Medema RH. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene 29:2281-91.
28. Ahn JY, Schwarz JK, Piwnica-Worms H, Canman CE. Threonine 68 phosphorylation by ataxia telangi-ectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res 2000; 60:5934-6.
29. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 2000; 97:10389-94.
30. Lee CH, Chung JH. The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation. J Biol Chem 2001; 276:30537-41.
31. Stevens C, Smith L, La Thangue NB. Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol 2003; 5:401-9. (Pubitemid 36592262)
32. Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L, et al. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol 2003; 5:552-8. (Pubitemid 36781090)
33. Stiewe T, Putzer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 2000; 26:464-9.
34. Stolz A, Ertych N, Kienitz A, Vogel C, Schneider V, Fritz B, et al. The CHK2-BRCA1 tumor suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol 12:492-9.
35. Holland AJ, Cleveland DW. Boveri revisited: Chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 2009; 10:478-87.
36. Xu X, Tsvetkov LM, Stern DF. Chk2 activation and phosphorylation- dependent oligomerization. Mol Cell Biol 2002; 22:4419-32. (Pubitemid 34556608)